We are live on
!
Find out more
QC
Quantessence Capital Portfolio holdings
AUM
$20.5M
1-Year Est. Return
71.02%
This Fund
S&P 500
This Quarter
Est. Return
+14.43%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$60.2M
(-15%)
Cap. Flow
-$87.3M
Cap. Flow
% of AUM
-25.71%
Top 10 Holdings %
Top 10 Hldgs %
46.41%
Holding
483
New
151
Increased
11
Reduced
18
Closed
302
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AZEK
The AZEK Co
AZEK
|
+$58.6M |
| 2 |
RDFN
Redfin
RDFN
|
+$35.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$8.53M |
| 4 |
Sprouts Farmers Market
SFM
|
+$7.45M |
| 5 |
Insmed
INSM
|
+$5.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$30.3M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$12.3M |
| 3 |
ExxonMobil
XOM
|
+$11.3M |
| 4 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$10.8M |
| 5 |
Pfizer
PFE
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 31.47% |
| 2 | Real Estate | 13.23% |
| 3 | Healthcare | 10.04% |
| 4 | Financials | 9.26% |
| 5 | Consumer Discretionary | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Performance Food Group
PFGC
$17.5B
| – | – |
-13,576
| Closed | -$1.07M |
|
|
PINC
377
DELISTED
Premier
PINC
| – | – |
-51,073
| Closed | -$985K |
|
378
ePlus
PLUS
$2.33B
| – | – |
-4,000
| Closed | -$244K |
|
379
Protalix BioTherapeutics
PLX
$191M
| – | – |
-51,243
| Closed | -$131K |
|
380
Philip Morris
PM
$301B
| – | – |
-16,100
| Closed | -$2.56M |
|
381
Plexus
PLXS
$6.81B
| – | – |
-1,900
| Closed | -$243K |
|
382
Perdoceo Education
PRDO
$1.9B
| – | – |
-8,000
| Closed | -$201K |
|
383
Progress Software
PRGS
$1.55B
| – | – |
-4,400
| Closed | -$227K |
|
384
Personalis
PSNL
$1.26B
| – | – |
-28,495
| Closed | -$100K |
|
|
P
385
Everpure Inc
P
$24.8B
| – | – |
-22,825
| Closed | -$1.01M |
|
386
Patterson-UTI
PTEN
$3.87B
| – | – |
-72,700
| Closed | -$598K |
|
387
Protagonist Therapeutics
PTGX
$8.75B
| – | – |
-8,900
| Closed | -$430K |
|
388
Qorvo
QRVO
$7.63B
| – | – |
-25,800
| Closed | -$1.87M |
|
389
Radian Group
RDN
$5.14B
| – | – |
-50,600
| Closed | -$1.67M |
|
390
RPC Inc
RES
$1.24B
| – | – |
-13,008
| Closed | -$71.5K |
|
391
Resideo Technologies
REZI
$5.23B
| – | – |
-13,900
| Closed | -$246K |
|
392
Regions Financial
RF
$26.3B
| – | – |
-63,600
| Closed | -$1.38M |
|
393
Relay Therapeutics
RLAY
$4.02B
| – | – |
-12,650
| Closed | -$33.1K |
|
394
RenaissanceRe
RNR
$13.8B
| – | – |
-2,700
| Closed | -$648K |
|
395
Roivant Sciences
ROIV
$25.2B
| – | – |
-12,513
| Closed | -$126K |
|
396
Roku
ROKU
$21.1B
| – | – |
-14,482
| Closed | -$1.02M |
|
397
Regal Rexnord
RRX
$14.2B
| – | – |
-1,800
| Closed | -$205K |
|
398
Reliance Steel & Aluminium
RS
$20.8B
| – | – |
-8,500
| Closed | -$2.45M |
|
399
Rezolute
RZLT
$480M
| – | – |
-34,533
| Closed | -$100K |
|
400
Saia
SAIA
$11.3B
| – | – |
-1,234
| Closed | -$431K |
|
Similar funds
FS
BC
HAM
DP
SPC
IW
SRHG
MPW
Quantessence Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Quantessence Capital held 483 positions worth $340M, down 15% from $400M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Quantessence Capital withdrew a net $87.3M in Q2 2025, closing 302 positions and reducing 18 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $30.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 11% a quarter earlier, followed by Real Estate and Healthcare.
Against the trend, Quantessence Capital opened a new position in The AZEK Co worth $63.6M.
- Quantessence Capital's largest Q2 2025 buy was The AZEK Co: 1,170,131 shares worth $63.6M.
- Quantessence Capital added most to Merck in Q2 2025, an estimated $3.19M increase.
- Quantessence Capital's biggest Q2 2025 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $1.84M.
- Quantessence Capital fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $30.3M.
- Quantessence Capital's ten largest holdings make up 46% of its $340M portfolio in Q2 2025.
- Quantessence Capital opened 151 new positions and closed 302 in Q2 2025.
- Quantessence Capital's portfolio value fell 15% quarter-over-quarter to $340M.
Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.